# Validation of a Treatment Algorithm for Poor-Risk NSGCTnon Seminomatous Germ-cell Tumors

> **NCT05705687** · NA · RECRUITING · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 150 (estimated)

## Conditions studied

- Non-Seminomatous Germ Cell Tumor

## Interventions

- **DRUG:** BEP Protocol
- **DRUG:** Dose-dense regimen
- **PROCEDURE:** Early tumor resection or HD-CT

## Key facts

- **NCT ID:** NCT05705687
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-05
- **Primary completion:** 2031-02
- **Final completion:** 2037-02
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05705687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05705687, "Validation of a Treatment Algorithm for Poor-Risk NSGCTnon Seminomatous Germ-cell Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05705687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*